Skip to main content

The Oncology Pharmacist® features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice.

Featured Articles

  • BEST PRACTICES
  • HEALTHCARE EQUITY
  • BIOMARKERS

Top Trending Articles

FDA News: August 9, 2023, to August 14, 2023
“What’s in It for Me?” Helping Patients Understand Oncology Clinical Trials
RIT Researcher Develops Math Models to Help Predict Patients’ Medication Adherence

In the Literature

Consumption of Ultra-Processed Foods Linked to Higher Cancer Risk
RIT Researcher Develops Math Models to Help Predict Patients’ Medication Adherence
Pegfilgrastim Can Be Safely Administered on Same Day as Chemotherapy in Patients with Lymphoma

Healthcare Disparities

Study Shows Health Insurance Status Mediates Racial and Ethnic Inequities in Advanced-Stage Cervical Cancer
Addressing Health Equity in Bladder Cancer Care
Older Patients of Color Less Likely to Receive Opioids for Cancer Pain at End of Life

Practical Issues for Pharmacists

Tornado Sweeps Through Pfizer’s Storage and Manufacturing Facility
ASHP Well-Being Ambassador Program Inspires Participants to Get Creative in Addressing Burnout
Any-Occupation versus Own-Occupation Disability Insurance for Pharmacists

Featured Video

Helping Patients with Multiple Myeloma Comply with Their Therapy Requires a Team Approach

Successfully getting patients with multiple myeloma to follow their therapy regimen often requires a team approach. Please join Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they outline which team members they utilize and how they use this technique at their institutions.
View Video
Video Library

SEPTEMBER SPOTLIGHT

  • September is Prostate Cancer Awareness Month. Take our quiz and explore our articles to stay up to date on prostate cancer.

    Quick Quiz View Prostate Cancer Articles

  • Prostate Cancer

    Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is a malignancy that originates in blood-forming cells (called myeloid cells) found in bone marrow. According to the American Cancer Society, approximately 8990 individuals (5250 men and 3740 women) in the United States will be diagnosed with chronic myeloid leukemia in 2019, and approximately 1140 individuals (660 men and 480 women) will die from the disease in the same year. How much do you know about chronic myeloid leukemia?

    Take Quiz

  • September Is Prostate Cancer Awareness Month: Learn What You Can Do to Support Your Patients

    According to the American Cancer Society, approximately 288,300 men in the United States will be diagnosed with prostate cancer in 2023 and 34,700 deaths will be attributed to the disease. September is Prostate Cancer Awareness Month, a time designated to help people learn more about the disease and to support those who are affected.

    Read More

FDA Updates

FDA News: August 9, 2023, to August 14, 2023
FDA News: April 17, 2023, to June 15, 2023
Talzenna Received a New Indication, With Enzalutamide, for Metastatic Castration-Resistant Prostate Cancer With HRR Gene Mutation

Upcoming Events

Value-Based Care
 

Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions
Study Confirms Cost Savings Associated with Telehealth Use in Cancer Care
AVBCC Panel Discusses Current and Future State of Value-Based Agreements